Biomea Fusion, Inc. (BMEA)
1.27
-0.03
(-2.31%)
USD |
NASDAQ |
Oct 02, 16:00
1.275
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion EPS Diluted (Quarterly) : -0.1151 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1151 |
| March 31, 2026 | -0.1717 |
| December 31, 2025 | 0.0638 |
| September 30, 2025 | -0.2741 |
| June 30, 2025 | -0.5105 |
| March 31, 2025 | -0.7989 |
| December 31, 2024 | -0.808 |
| September 30, 2024 | -0.9052 |
| June 30, 2024 | -1.034 |
| March 31, 2024 | -1.088 |
| December 31, 2023 | -0.9726 |
| September 30, 2023 | -0.7974 |
| June 30, 2023 | -0.7042 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.9819 |
| December 31, 2022 | -0.8598 |
| September 30, 2022 | -0.7807 |
| June 30, 2022 | -0.5911 |
| March 31, 2022 | -0.5619 |
| December 31, 2021 | -0.5052 |
| September 30, 2021 | -0.4341 |
| June 30, 2021 | -0.2897 |
| March 31, 2021 | -0.1943 |
| December 31, 2020 | -0.1161 |
| September 30, 2020 | -0.0394 |
| June 30, 2020 | -0.0102 |
| March 31, 2020 | -0.0132 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| REGENXBIO, Inc. | 0.4283 |
| Compass Therapeutics, Inc. | -0.1347 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.328M |
| Total Expenses (Quarterly) | 8.328M |
| Enterprise Value | 57.74M |
| Earnings Yield | -39.14% |
| Normalized Earnings Yield | -54.94 |